[Novel intracellular signal transduction of dopamine D2 receptor in schizophrenia].
Fukunaga
Kohji
K
fukunaga@mail.pharm.tohoku.ac.jp
Takeuchi
Yusuke
Y
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D019703:Calcineurin / Q000378:metabolism; D020013:Calcium Signaling; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D050556:Fatty Acid-Binding Proteins / Q000378:metabolism; D015525:Fatty Acids, Omega-3; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D006801:Humans; D011485:Protein Binding; D017448:Receptors, Dopamine D2 / Q000502:physiology*; D012559:Schizophrenia / Q000209:etiology*; D015398:Signal Transduction
D050556:Fatty Acid-Binding Proteins; D015525:Fatty Acids, Omega-3; D005231:Fatty Acids, Unsaturated; D017448:Receptors, Dopamine D2; C113776:dopamine D2L receptor; D048049:Extracellular Signal-Regulated MAP Kinases; D019703:Calcineurin; D000262:Adenylyl Cyclases